lines for self-monitoring of blood pressure (SBPM). We aimed to demonstrate the equivalence of SBPM with ambulatory blood pressure monitoring (ABPM) in the assessment of hypertension. A total of 87 consecutive subjects referred from primary care for standard ABPM underwent a 1-week period of SBPM, as defined by the ESH guidelines, either before or after ABPM. There was no difference in mean blood pressure (BP): SBPM 142/ 87 mm Hg, daytime average ABPM 141/86 mm Hg. The intra-class correlation coefficient was 0.72 and 0.89 for systolic and diastolic pressure, respectively. SBPM is concordant with ABPM in classifying subjects as hypertensive or normotensive in 87% of cases (j ¼ 0.56). The coefficient of variation of SBPM compared with ABPM was 5%. In answer to a direct question 81% of subjects preferred SBPM to ABPM. The current self-monitoring schedule recommended by the ESH, AHA and ASH is valid. The mean BP obtained from SBPM is equivalent to awake-time BP on ABPM, the accepted reference standard for 'out of office' BP measurement. SBPM is simpler to carry out, preferred by patients and should be considered on a par with ABPM.
Introduction
Although the evidence that 'out of office' blood pressure (BP) better predicts cardiovascular outcome than clinic readings is strong, [1] [2] [3] [4] [5] [6] there remains a great deal of uncertainty as to how this technology should be used in clinical practise. Ambulatory BP monitoring (ABPM) has come to be regarded as the 'gold standard', probably because it has been studied more extensively than self-monitoring of BP (SBPM). 7, 8 Although ABPM has been shown to be cost effective in establishing the diagnosis of true hypertension 9, 10 the equipment remains expensive and may not be practicable for the diagnosis and long-term management of hypertension in a primary care setting. 11 Electronic self-monitors are at least an order of magnitude cheaper than ambulatory devices and are increasingly being used by the public with or without clinician support. Up to 50% of the hypertensive population in the United States of America admit to using such a monitor 12 and, even in the United Kingdom this figure is as high as 10% of the general population. 13 National and international guidelines 7, [14] [15] [16] have all indicated the potential value of SBPM but, until recently, detailed advice on how such methodology should be applied have been lacking. In 2008 the European Society of Hypertension (ESH) published detailed guidelines on how patients and health care professionals should use SBPM to diagnose hypertension 17 and, although these were somewhat empirical, they have been endorsed by the American Heart Association, the American Society of Hypertension 18 and a recent British national conference. 19 The guidance advises that BP be measured (in duplicate), morning and evening for 7 days (28 readings) and that the first day's results (generally higher in most studies) are discarded. The final BP is therefore an average of 24 measurements. Given the apparent primacy of ABPM we planned our study to evaluate the 'accuracy' of such a guideline against, arguably, the most commonly used ambulatory monitor in the world, Spacelabs. 20 
Methods

Study population
The Edinburgh Direct Access ABPM service has been running for over 10 years 21 and allows primary care physicians to obtain ABPM, generally to confirm or exclude hypertension. We invited sequential patients, referred routinely, treated or untreated, to participate in our comparative study. Patients with major illness, inability to use the home monitor, atrial fibrillation or pregnancy were excluded. In groups of six, patients were allocated to carry out either SBPM or ABPM first that is, all patients had a single episode of monitoring with each device. All were taught, by research nurses, how to use a validated self-monitor ('WatchBP Home', Microlife 22 ) and written instructions were provided.
BP measurement
Self-monitoring of BP was carried out four times per day, as per the ESH guidelines. Patients made two measurements in the morning between 0700 h and 0900 h and two in the evening between 1900 h and 2100 h. The self-monitoring device used in this study is programmed for a 60 s delay between activating the first BP measurement and cuff inflation and 60 s between readings. After each duplicate reading, an average is displayed and patients are asked to note this down. All patients were aware of the memory function on the device and the written readings were compared to establish reporting accuracy. After 7 days, an average of 24 readings is displayed (first day readings automatically disregarded for habituation) and this figure was used for comparison with the awake-time average from the ABPM.
Ambulatory BP monitoring was carried out using a non-invasive oscillometric device (Spacelabs 90207-Spacelabs, Redmond, WA, USA) under standardized conditions-24 h recordings were made, as that is the standard operating procedure for the service. An appropriate sized cuff was applied to the non-dominant arm and readings obtained at 30 0 intervals. Awake-time averages were calculated on the basis of patient diaries 23 and this was compared with mean self-measured BP. The raw BP data are downloaded to a Microsoft Access database then transferred to a Microsoft excel spreadsheet for analysis. All patients included had 485% success on ABPM and 483% success on SBPM (nX20 BP measurements with either device).
Both ABPM and SBPM used the same arm and cuff size for measurements.
Both BP monitoring procedures (24 h of ABPM and 1 week of SBPM) took place within an 8-day period. All patients gave written informed consent after at least 24 h of receiving a written information sheet and the local ethics committee approved the study.
A total of 87 subjects were enrolled, in accordance with the number accepted by the AAMI 24 and the original British Hypertension Society protocol for the validation of BP monitoring devices. 25 Age, smoking status, ethnicity and presence or absence of diabetes was noted and all patients were asked to complete a short questionnaire on the experience of each BP-monitoring period.
Hypertension was defined, a priori, as X135/ 85 mm Hg on SBPM or awake average on ABPM. 16, 26 Statistical analysis The hypothesis to be tested was that there is no difference between ABPM and SBPM in terms classification of 'hypertensive' or 'normotensive' or BP measured as a continuous variable that is, to prove the validity of the ESH monitoring schedule.
Classification as hypertensive or normotensive and how many subjects change category is expressed as a percentage. To remove the possibility of subjects being classified the same as a result of chance, Cohen's Kappa statistic (k) is also used. This is a relative statistic with a value of 0 denoting no agreement and 1 denoting perfect agreement. Comparison of BP as a continuous variable is examined using the intra-class correlation coefficient (also a relative statistic) and using a repeatability coefficient/Bland Altman plot. 27, 28 All BP results are expressed as mean ± s.d.
Results
All subjects completed the study. The mean age of participants was 57 years (±12) and 48% were male. Approximately a quarter (27%, n ¼ 23) were on antihypertensive treatment, 8% (n ¼ 7) were smokers and 7% (n ¼ 6) had diabetes.
The awake-time average ABPM was 141/86 (±11/ 10) mm Hg and there was no significant impact on this figure if the first 2 h of BP readings of the ABPM, the so-called 'white coat window', 29 were removed (data not shown).
Average SBPM, 142/87 ( ± 12/10) mm Hg was no different from the awake ABPM and there was no evidence of an order effect that is, the second period of monitoring was not significantly different from the first (data not given).
With respect to classification of hypertensive or not, SBPM was concordant with ABPM in 87% of cases, k ¼ 0.56 (95% confidence interval 0.34-0.78). Intra-class correlation coefficient and repeatability coefficients describe agreement when BP is expressed as a continuous variable between methods (Table 1 ). Figure 1 illustrates the Bland Altman plot for SBPM vs ABPM.
Patient preference
Subject questionnaires were completed by 83 of 87 subjects. Of these, 81% preferred SBPM to ABPM. The main reasons for preference given were: the ability to instantly see their BP; being more 'in control'; less embarrassment in public; and no interference in sleep. In all, 13 subjects reported difficulty in adhering to the time constraints of the SBPM, but only 2 reported difficulty in completing 1 week of monitoring. Three subjects reported an increase in anxiety during SBPM.
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The 19% of subjects who preferred ABPM indicated that this was because it was 'over in 24 h'.
Reporting accuracy
The memory was checked and compared with the self-reported BP results following SBPM with 100% accuracy documented.
Time required
All SBPM and ABPM monitors were fitted by the same three nursing staff throughout the study. The standard appointment time for fitting an ambulatory device is 30 min and this does not include time to download the monitor after recording. Although the exact timing was not a part of the study, the time taken to explain and demonstrate self-monitoring was substantially less, between 10 and 15 min per subject.
Discussion
Ambulatory BP monitoring is firmly established as the reference standard for non-invasive BP monitoring, 7, 14 backed up by a significant amount of literature. At present, there is a debate over the exact place for ambulatory and self monitoring. 30, 31 However, there is consensus that self monitoring does provide a cheap and patient friendly method of BP monitoring in the management of hypertension. The ESH described a schedule of self-monitoring, 18 which was somewhat pragmatic but until now has lacked any real evidence. We have demonstrated for the first time that mean BP obtained by SBPM using the ESH/the American Society of Hypertension guidelines is no different to awake-time BP on ABPM.
The agreement between hypertensive/normotensive classification is only moderate but this is only to be expected given the well-known problems with reproducibility when any continuous physiological variable is dichotomized. Agreement between SBPM and ABPM is improved to substantial (systolic BP) or excellent (diastolic BP) when BP is expressed as a continuous variable.
We have also shown that the majority of patients preferred SBPM and that it did not cause any significant anxiety, some specifically commenting that they found it useful to know their BP. The only drawback of SBPM is the absence of information regarding the nocturnal BP. However, until a consensus is reached on the treatment of nocturnal pressure, the majority of treating physicians will continue to treat hypertension dependant on daytime BP. 32 The superiority of out of office BP measurement Ambulatory BP monitoring is a better predictor of cardiovascular mortality than office BP, irrespective of whether the general population, 4,33 untreated 1, 6, 34 or treated 2 hypertensive population are studied. As such it has generally been accepted as the reference standard for 'out of office' BP measurement. The structured nature of the comparison in this study arguably explains why we have demonstrated a higher correlation between SBPM and ABPM than in previous studies. [35] [36] [37] As SBPM is equivalent to ABPM at predicting target organ damage, 37, 38 it could be surmised that differences between ABPM and SBPM are simply because of different measurement strategies, rather than reflecting any real difference in BP.
Self-monitoring of BP has a stronger relationship to cardiovascular risk than OBP in the general population 39, 40 and in those with treated hypertension. 41 Both ABPM and SBPM can identify true hypertension, white coat hypertension and masked hypertension (normal office BP and elevated out of office BP). White coat and masked hypertension are common, each affecting 10-15% of the general population, with the latter associated with a doubling of cardiovascular risk. 42 Out of office BP is more reproducible and therefore more likely to represent true BP than OBP. 43, 44 Indeed, a recent meta-analysis describing the changes in BP in subjects treated with antihypertensive medication or placebo has demonstrated the improved stability 45 There is also evidence that the use of SBPM can lead to improved compliance with antihypertensive medication 46 and improved BP control. 47, 48 Although ABPM has been shown to be costeffective 9,10 in diagnosing hypertension, it is impractical for assessing and managing all patients in primary care. SBPM is cheaper than ABPM with equivalent diagnostic accuracy and has been proposed by some as the way forward for managing hypertension. 11, 17, 18 Central to the debate on the use of self-monitoring is the question of how many and how often measurements are made. Sole reliance on clinic or office readings may result in misclassification of patients, either hypertensive or normotensive, in upto 69% of cases. 49 Ohkubo et al. 50 have indicated that even one self-measurement in the morning is more predictive of stroke than OBP, but the predictive precision improves as the number of readings increases. There remains significant debate on the frequency and mode of operation for SBPM.
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Conclusion
We have demonstrated that the current ESH guidelines for self-monitoring are valid when compared directly with ABPM in terms of mean BP and diagnosing both normality and hypertension. Given the vast amount of evidence regarding the superiority of out of office BP measurement, surely selfmonitoring of BP is the way forward, as advocated in a recent clinical review? 19 
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